表紙
市場調查報告書
商品編碼
1101573

臨床決策支持系統(CDSS)全球市場:按組件(服務,軟件),交付模式(本機,雲端),產品(獨立,集成),應用(最新,治療,診斷),未來雙向性別預測(主動,被動)2027

Clinical Decision Support Systems (CDSS) Market by Component (Services, Software), Delivery (On-premise, Cloud), Product (Standalone, Integrated), Application (Advanced, Therapeutic, Diagnostic), Interactivity (Active, Passive) -Global Forecasts -2027

出版日期: | 出版商: MarketsandMarkets | 英文 232 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球臨床決策支持系統 (CDSS) 市場預計將從 2022 年的 15 億美元增長到 2027 年的 22 億美元。

此外,預測期內的複合年增長率為 7.9%。該市場的增長是由於政府為促進採用醫療 IT 解決方案而實施的各種法規和舉措、與 CDSS 集成的電子病歷的普及、公司之間業務合作和聯盟的擴大以及用藥錯誤的發生。因素包括增加的費率、移動健康和大數據工具的開發。

“預計軟件板塊在預測期內將呈現最高增速”

2021 年,服務部門佔據了該市場的最大份額。這部分的增長是由於培訓、開發、安裝、諮詢和維護等服務的經常性。

“預計2022年臨床決策支持系統市場將在本地解決方案領域佔有最大份額。”

按交付方式來看,2021 年本地交付方式佔據最大份額。另一方面,基於雲的交付模式預計將以最高的複合年增長率增長,因為它們的可擴展性、靈活性、可負擔性以及該模式產生的低資本和運營成本。

“傳統的 CDSS 細分市場在臨床決策支持系統的全球市場中佔有最大份額”

按應用來看,傳統 CDSS 細分市場將在 2021 年佔據最大份額。傳統 CDSS 擁有最大的市場份額,因為醫療保健提供者越來越多地採用 CDSS,主要是為了在護理點向護理人員提供指導和提醒。

“集成CDSS在全球臨床決策支持系統市場中佔有最大份額”

按產品劃分,集成 CDSS 細分市場將在 2021 年擁有最大的市場份額。這一細分市場的很大一部分是由於醫療環境和組織中越來越多地採用集成 CDSS。

“治療性 CDSS 細分市場預計在預測區間內以最高 CAGR 增長”

按類型劃分,治療性 CDSS 細分市場將在 2021 年主導該市場。據估計,在預測期內,它還將以高複合年增長率增長。這一細分市場的大份額和高增長率可能是由於臨床醫生對治療性 CDSS 的偏好等因素,因為它與臨床工作流程的高度兼容性。它也很容易使用,因為它不會限制醫療保健專業人員的自主權。

“基於知識的 CDSS 細分市場在全球臨床決策支持系統市場中佔有最大份額”

從模型來看,基於知識的 CDSS 細分市場將在 2021 年佔據最大份額。還估計在預測間隔期間記錄最高的複合年增長率。該部分的巨大份額和高增長可歸因於這些系統的幾個好處,例如協助臨床醫生進行基於知識的推理以及在面對不確定性時做出臨床決策。此外,這些系統可以集成到臨床工作流程中,並且不太可能導致錯誤。

“活躍的 CDSS 行業預計將在預測期內以最高的複合年增長率增長”

從交互性水平來看,活躍的 CDSS 細分市場預計將在 2021 年擁有最大的市場份額,並在預測期內以最高的複合年增長率增長。

“住院環境在臨床決策支持系統的全球市場中佔據最大份額”

2021年,按offer模式來看,住院設置將佔據最大份額。在住院領域,需要獲取和分析大量的患者數據,因此正在引入集成的醫療IT模塊。

“2022年,北美將主導臨床決策支持系統市場”

2021 年,北美在全球臨床決策支持系統市場的份額最大。北美市場的巨大份額被認為是由於對醫療 IT 解決方案的大量投資、有利於引入 CDSS 的監管命令、該地區巨頭的存在以及美國和加拿大的劑量錯誤增加。

目錄

第 1 章介紹

第 2 章調查方法

第 3 章執行摘要

第 4 章重要考慮

第 5 章市場概述

  • 簡介
  • 市場動態
  • COVID-19 對臨床決策支持系統市場的影響
  • 價值鏈分析
  • 案例研究
  • 生態系統分析
  • 技術分析
  • 監管分析
  • 波特五力分析
  • 行業趨勢
  • 價格分析
  • 會議和網絡會議
  • 商業模式

第 6 章臨床決策支持系統市場:按組件

  • 簡介
  • 服務
  • 軟件
  • 硬件

第 7 章臨床決策支持系統市場:按產品分類

  • 簡介
  • 集成 CDSS
  • 獨立 CDSS

第 8 章臨床決策支持系統市場:按類型

  • 簡介
  • 治療性 CDSS
  • 診斷 CDSS

第 9 章臨床決策支持系統市場:按模型

  • 簡介
  • 知識庫 CDSS
  • 非知識庫 CDSS

第 10 章臨床決策支持系統市場:按交付方式

  • 簡介
  • 本機 CDSS
  • 雲端 CDSS

第 11 章臨床決策支持系統市場:按應用

  • 簡介
  • 常規 CDSS
  • 最新 CDSS

第 12 章臨床決策支持系統市場:按交互級別

  • 簡介
  • 主動 CDSS
  • 被動 CDSS

第 13 章臨床決策支持系統市場:通過設置

  • 簡介
  • 住院患者設置
  • 門診治療設置

第 14 章臨床決策支持系統市場:按地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 其他亞太國家
  • 其他國家
    • 拉丁美洲
    • 中東/非洲

第 15 章競爭態勢

  • 概覽
  • 主要公司/領先公司的戰略
  • 主要公司的收入份額分析
  • 企業市場排名 (2021)
  • 競爭基準
  • 競爭領導力圖譜
  • 競爭領導力映射-初創公司/中小企業
  • 競爭形勢/趨勢
    • 交易

第 16 章公司簡介

  • 主要公司
    • CERNER CORPORATION
    • IBM WATSON HEALTH
    • CHANGE HEALTHCARE
    • ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
    • ATHENAHEALTH
    • EPIC SYSTEMS CORPORATION
    • ELSEVIER B.V. (A DIVISION OF RELX GROUP)
    • ZYNX HEALTH
    • WOLTERS KLUWER N.V.
    • PHILIPS HEALTHCARE (A SUBSIDIARY OF ROYAL PHILIPS)
    • MEDITECH
  • 其他公司
    • NEXTGEN HEALTHCARE
    • SIEMENS HEALTHINEERS
    • EBSCO HEALTH (A DIVISION OF EBSCO INDUSTRIES, INC.)
    • GE HEALTHCARE
    • ECLINICALWORKS
    • RAMPMEDICAL
    • THE MEDICAL ALGORITHMS COMPANY
    • HERA-MI
    • CUREMD
    • CARECLOUD
    • VISUALDX
    • STANSON HEALTH
    • FIRST DATABANK
    • STRATA DECISION TECHNOLOGY

第 17 章附錄

目錄
Product Code: HIT 2237

The global clinical decision support systems (CDSS) market is projected to reach USD 2.2 billion by 2027 from USD 1.5 billion in 2022, at a CAGR of 7.9% during the forecast period. The growth of this market is driven by the various government regulations and initiatives that are implemented to promote the adoption of HCIT solutions, increase in the adoption of CDSS integrated EHRs, growth in collaborations and partnerships between competitor companies, rgrowing incidence in medication errors, and the development of mHealth and big data tools.

However, high investments for the implementation of CDSS and interoperability issues coupled with rising data security concerns are factors expected to restrain the growth of this market during the forecast period.

"Software segment is expected to grow at the highest rate during the forecast period"

On basis of component the CDSS market is segmented into : services, software, and hardware. In 2021, the services segment accounted for the largest share of this market. Growth in this segment is attributed to the recurring nature of the services such as training and development, installation, consulting, and maintenance.

"The On-premise solutions segment is estimated to account for the largest share of the Clinical decision support systems market in 2022"

On basis of delivery mode , Clinical decision support systems are delivered to end users through on-premise and cloud-based modes. The on-premise mode of delivery accounted for the largest share of the clinical decision support systems market in 2021. The cloud-based mode of delivery, on the other hand, is estimated to grow at the highest CAGR due to lower capital expenses and operational costs incurred in this model, alongside its scalability, flexibility, and affordability.

"Conventional CDSS segment accounted for the largest share of the global Clinical decision support systems market"

Based on application, the CDSS market is segmented into conventional CDSS and advanced CDSS. In 2021, the conventional CDSS segment accounted for the largest share of the market. Conventional CDSS has largest share in the market primarily due to the increasing adoption of CDSS by healthcare organizations to provide guidance & reminders to caregivers at the point-of-care.

"Integrated CDSS segment accounted for the largest share of the global Clinical decision support systems market"

Based on product, the CDSS market is segmented into integrated CDSS and standalone CDSS. In 2021, the integrated CDSS segment accounted for the largest share of the market. The large share of this segment can be attributed to the growing adoption of integrated CDSS in healthcare settings and organizations.

"The therapeutic CDSS segment is expected to grow with the highest CAGR during the forecast period"

Based on type, the clinical decision support systems market is segmented into therapeutic CDSS and diagnostic CDSS. The therapeutic CDSS segment dominated this market in 2021. This segment is estimated to grow at a higher CAGR during the forecast period. This segment's large share and high growth rate can be attributed to factors such as therapeutic CDSS being preferred by clinicians over diagnostic CDSS as it is better compatible with clinical workflows. It is also convenient to use, as it doesn't restrict the healthcare provider's autonomy.

"Knowledge-based CDSS segment accounted for the largest share of the global Clinical decision support systems market"

Based on the model, the CDSS market is segmented into knowledge-based CDSS and non-knowledge-based CDSS. In 2021, the knowledge-based CDSS segment accounted for the largest share of the market. This segment is also estimated to register the highest CAGR during the forecast period. The large share and high growth of this segment can be attributed to the several benefits of these systems, such as helping clinicians with knowledge-based reasoning and to make clinical decisions in uncertainties. These systems can also be integrated into clinical workflows and are less prone to errors.

"The Active CDSS segment is expected to grow with the highest CAGR during the forecast period"

Based on the interactivity level, the CDSS market can be segmented into active CDSS and passive CDSS. The active CDSS segment accounted for the largest share of the market in 2021 and is projected to grow at the highest CAGR during the forecast period.

"Inpatient settings accounted for the largest share of the global Clinical decision support systems market"

Based on setting, the CDSS market is segmented into inpatient and ambulatory care settings. Inpatient settings accounted for the largest share of the CDSS market in 2021. Inpatient settings have to capture and analyze large volumes of patient data, this results in the increasing adoption of integrated healthcare IT modules.

"North America to dominate the Clinical decision support systems market in 2022"

North America accounted for the largest share of the global clinical decision support systems market in 2021. The large share of the North American market can be attributed to the noticeable investments in HCIT solutions, regulatory mandates that favor the implementation of CDSS, the presence of key market players in the region, and the rise in medication errors in the US and Canada.

The Asia Pacific market is projected to register the highest CAGR during the forecast period, owing to the factors such as the presence of a large geriatric population, improved government regulations, the high burden of chronic diseases, and the growing focus of various market players on emerging Asian countries are expected to drive the growth of the CDSS market in Asia.

Breakdown of supply-side primary interviews, by company type, designation, and region:

  • By Company Type: Tier 1 (45%), Tier 2 (35%), and Tier 3 (20%)
  • By Designation: C-level (26%), Director-level (17%), and Others (57%)
  • By Region: North America (40%), Europe (20%), Asia Pacific (30%), and RoW (10%)

Prominent players operating in the CDSS market are Cerner Corporation (US), Change Healthcare (US), Epic Systems (US), MEDITECH (US), Philips Healthcare (Netherlands), Wolters Kluwer N.V. (Netherlands), Zynx Health (US), Elsevier B.V. (UK), IBM Watson Health (US), Allscripts Healthcare LLC (US), athenahealth (US), NextGen Healthcare (US), Siemens Healthineers (US), EBSCO Health (US), GE Healthcare (US), eClinicalWorks (US), RAMPMedical (Germany), The Medical Algorithms Company Limited (UK), Hera-MI (France), CureMD Healthcare (US), CareCloud, Inc (US), Visual DX (US), Stanson Health (US), First Databank, Inc (US), and Strata Decision Technology (US).

Research Coverage

  • The report studies the Clinical decision support systems market based on component, delivery mode, product, model, interactivity level, application, setting, type, and region
  • The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth
  • The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders
  • The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total Clinical decision support systems market
  • The report forecasts the revenue of market segments with respect to five major regions

Key Benefits of Buying the Report:

The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the Clinical decision support systems market and provides them information on key market drivers, restraints, challenges, and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 CLINICAL DECISION SUPPORT SYSTEM MARKET: INCLUSIONS & EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • FIGURE 1 CDSS MARKET SEGMENTATION
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
    • 1.5.1 SCOPE-RELATED LIMITATIONS
    • 1.5.2 METHODOLOGY-RELATED LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 2 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY RESEARCH
    • FIGURE 3 PRIMARY SOURCES
      • 2.1.2.1 Key industry insights
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION METHODOLOGY
    • FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • 2.3 MARKET ESTIMATION
    • FIGURE 6 RESEARCH METHODOLOGY: MARKET ESTIMATION
    • 2.3.1 APPROACH: END USER-BASED MARKET ESTIMATION
    • FIGURE 7 MARKET-SIZE ESTIMATION
  • 2.4 MARKET DATA ESTIMATION AND TRIANGULATION
    • FIGURE 8 DATA TRIANGULATION METHODOLOGY
  • 2.5 ASSUMPTIONS FOR THE STUDY
  • 2.6 RISK ASSESSMENT
    • TABLE 1 RISK ASSESSMENT: CLINICAL DECISION SUPPORT SYSTEMS MARKET
  • 2.7 LIMITATIONS

3 EXECUTIVE SUMMARY

    • FIGURE 9 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2022 VS. 2027 (USD MILLION)
    • FIGURE 10 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
    • FIGURE 11 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
    • FIGURE 12 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2022 VS. 2027 (USD MILLION)
    • FIGURE 13 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
    • FIGURE 14 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2022 VS. 2027 (USD MILLION)
    • FIGURE 15 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2022 VS. 2027 (USD MILLION)
    • FIGURE 16 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2022 VS. 2027 (USD MILLION)
    • FIGURE 17 GEOGRAPHICAL SNAPSHOT OF THE CLINICAL DECISION SUPPORT SYSTEMS MARKET

4 PREMIUM INSIGHTS

  • 4.1 CLINICAL DECISION SUPPORT SYSTEMS MARKET OVERVIEW
    • FIGURE 18 RISING GOVERNMENT INITIATIVES FOR THE ADOPTION OF HCIT SOLUTIONS DRIVE THE MARKET GROWTH
  • 4.2 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT AND COUNTRY
    • FIGURE 19 US DOMINATED THE MARKET IN NORTH AMERICA (2021)
  • 4.3 CLINICAL DECISION SUPPORT SYSTEMS MARKET SHARE, BY PRODUCT
    • FIGURE 20 INTEGRATED CDSS SEGMENT TO DOMINATE THE MARKET FROM 2022 TO 2027
  • 4.4 CLINICAL DECISION SUPPORT SYSTEMS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 21 ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 22 CLINICAL DECISION SUPPORT SYSTEMS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Implementation of government regulations & initiatives to promote the adoption of HCIT solutions
      • 5.2.1.2 Increasing adoption of CDSS-enabled EHRs
      • 5.2.1.3 Growing collaborations & partnerships among stakeholders
    • TABLE 2 INDICATIVE LIST OF COLLABORATIONS BETWEEN ORGANIZATIONS FROM 2020 TO 2022
      • 5.2.1.4 Growing incidence of medication errors
      • 5.2.1.5 Development of big data and mHealth tools
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Data security concerns related to cloud-based CDSS
      • 5.2.2.2 Inadequate interoperability
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 The growth potential of emerging markets
      • 5.2.3.2 Social media integration and rising technological advancements
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Requirement of high investments for the implementation of CDSS infrastructure
      • 5.2.4.2 Shortage of skilled IT professionals in the healthcare industry
  • 5.3 IMPACT OF COVID-19 ON THE CLINICAL DECISION SUPPORT SYSTEMS MARKET
  • 5.4 VALUE-CHAIN ANALYSIS
    • FIGURE 23 CLINICAL DECISION SUPPORT SYSTEMS MARKET: VALUE-CHAIN ANALYSIS (2021)
  • 5.5 CASE STUDIES
    • 5.5.1 IMPROVING RESPONSE PHYSICIAN EFFICIENCY AND TIME
    • TABLE 3 CASE 1: NEED TO PROVIDE BETTER FACILITIES
    • 5.5.2 IMPROVING EFFICIENCY AND CARE WITH AI
    • TABLE 4 CASE 2: IMPROVING EFFICIENCY, ADOPTION, AND CARE EXPERIENCES WITH AI-POWERED CDS
    • 5.5.3 PROVIDING THE BEST PATIENT CARE
    • TABLE 5 CASE 3: FOCUS ON QUALITY AND SAFETY
  • 5.6 ECOSYSTEM ANALYSIS
    • FIGURE 24 CLINICAL DECISION SUPPORT SYSTEM MARKET: ECO SYSTEM ANALYSIS (2021)
  • 5.7 TECHNOLOGY ANALYSIS
    • TABLE 6 TECHNOLOGICAL DEVELOPMENTS BY LEADING VENDORS
  • 5.8 REGULATORY ANALYSIS
    • 5.8.1 HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT OF 1996 (HIPAA)
    • 5.8.2 HEALTH INFORMATION TECHNOLOGY FOR ECONOMIC AND CLINICAL HEALTH ACT OF 2009 (HITECH)
    • 5.8.3 CONSUMER PRIVACY PROTECTION ACT OF 2017
    • 5.8.4 NATIONAL CYBERSECURITY PROTECTION ADVANCEMENT ACT OF 2015
    • 5.8.5 CYBERSECURITY LAW OF THE PEOPLE'S REPUBLIC OF CHINA
    • 5.8.6 AFFORDABLE CARE ACT, 2010
  • 5.9 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 7 CDSS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • 5.10 INDUSTRY TRENDS
    • 5.10.1 RISING NEED FOR INTEROPERABILITY & INTEGRATION FOR HCIT SOLUTIONS
    • 5.10.2 GRADUAL SHIFT OF ACCOUNTABILITY FROM PAYERS TO PROVIDERS
    • 5.10.3 GROWING DEMAND FOR VALUE-BASED HEALTHCARE
  • 5.11 PRICING ANALYSIS
    • TABLE 8 AVERAGE SELLING PRICE OF CDSS SOLUTIONS, BY PRODUCT (2021)
  • 5.12 CONFERENCES AND WEBINARS
  • 5.13 BUSINESS MODELS
    • FIGURE 25 BENEFITS OF HYBRID BUSINESS MODELS

6 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT

  • 6.1 INTRODUCTION
    • TABLE 9 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
  • 6.2 SERVICES
    • 6.2.1 SERVICES SEGMENT TO DOMINATE THE MARKET FROM 2022-2027
    • TABLE 10 CLINICAL DECISION SUPPORT SERVICES MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 6.3 SOFTWARE
    • 6.3.1 THE USE OF EMR/EHR-INTEGRATED CDSS ENABLES ACCESS TO CENTRALIZED PATIENT DATABASES
    • TABLE 11 CLINICAL DECISION SUPPORT SOFTWARE MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 6.4 HARDWARE
    • 6.4.1 HARDWARE MUST BE FREQUENTLY UPGRADED OR REPLACED FOR THE OPTIMAL USE OF ADVANCED SOFTWARE
    • TABLE 12 CLINICAL DECISION SUPPORT HARDWARE MARKET, BY REGION, 2020-2027 (USD MILLION)

7 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT

  • 7.1 INTRODUCTION
    • TABLE 13 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
  • 7.2 INTEGRATED CDSS
    • 7.2.1 INTEGRATED CDSS IS WIDELY USED BY HEALTHCARE PROVIDERS TO IMPROVE THE QUALITY OF CARE AND REDUCE MEDICATION ERRORS
    • TABLE 14 INTEGRATED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 7.3 STANDALONE CDSS
    • 7.3.1 LACK OF INTEROPERABILITY WITH CPOE AND EHR TO RESTRAIN THE MARKET DEMAND
    • TABLE 15 STANDALONE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020-2027 (USD MILLION)

8 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE

  • 8.1 INTRODUCTION
    • TABLE 16 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
  • 8.2 THERAPEUTIC CDSS
    • 8.2.1 THERAPEUTIC CDSS IS MOST EFFECTIVE IN INTEGRATED CLINICAL WORKFLOWS AS IT REDUCES MEDICATION ERRORS
    • TABLE 17 THERAPEUTIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 8.3 DIAGNOSTIC CDSS
    • 8.3.1 DIAGNOSTIC CDSS GUIDES PHYSICIANS THROUGH A SYSTEMATIC DIAGNOSIS PROCESS
    • TABLE 18 DIAGNOSTIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020-2027 (USD MILLION)

9 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL

  • 9.1 INTRODUCTION
    • TABLE 19 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020-2027 (USD MILLION)
  • 9.2 KNOWLEDGE-BASED CDSS
    • 9.2.1 KNOWLEDGE-BASED CDSS MODELS USE CONDITIONAL LOGIC FOR DECISION-MAKING AND PROBLEM ANALYSIS
    • TABLE 20 KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 9.3 NON-KNOWLEDGE-BASED CDSS
    • 9.3.1 NON-KNOWLEDGE-BASED CDSS IMPLEMENTS ML AND AI ALGORITHMS TO EXPAND ITS USER-DEFINED KNOWLEDGE BASE
    • TABLE 21 NON-KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020-2027 (USD MILLION)

10 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE

  • 10.1 INTRODUCTION
    • TABLE 22 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020-2027 (USD MILLION)
  • 10.2 ON-PREMISE CDSS
    • 10.2.1 LICENSED SOFTWARE IS INSTALLED ON ON-PREMISE CDSS DELIVERY MODES
    • TABLE 23 ON-PREMISE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 10.3 CLOUD-BASED CDSS
    • 10.3.1 CLOUD-BASED CDSS IS PROJECTED TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
    • TABLE 24 CLOUD-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020-2027 (USD MILLION)

11 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION

  • 11.1 INTRODUCTION
    • TABLE 25 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
  • 11.2 CONVENTIONAL CDSS
    • 11.2.1 CONVENTIONAL CDSS IS USED TO ENHANCE HEALTH-RELATED DECISION-MAKING
    • TABLE 26 CONVENTIONAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 11.3 ADVANCED CDSS
    • 11.3.1 ADVANCED CDSS SEGMENT TO WITNESS HIGH GROWTH DURING THE FORECAST PERIOD
    • TABLE 27 ADVANCED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020-2027 (USD MILLION)

12 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL

  • 12.1 INTRODUCTION
    • TABLE 28 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020-2027 (USD MILLION)
  • 12.2 ACTIVE CDSS
    • 12.2.1 ACTIVE CDSS IS THE LARGEST AND THE FASTEST-GROWING SEGMENT IN THE CDSS MARKET
    • TABLE 29 ACTIVE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 12.3 PASSIVE CDSS
    • 12.3.1 PASSIVE CDSS CAUSES MINIMAL DISRUPTION TO WORKFLOWS
    • TABLE 30 PASSIVE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020-2027 (USD MILLION)

13 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING

  • 13.1 INTRODUCTION
    • TABLE 31 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020-2027 (USD MILLION)
  • 13.2 INPATIENT SETTINGS
    • 13.2.1 THE ADOPTION OF CDSS FOR INPATIENT SETTINGS HELPS IMPROVE PATIENT CARE WORKFLOWS
    • TABLE 32 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR INPATIENT SETTINGS, BY REGION, 2020-2027 (USD MILLION)
  • 13.3 AMBULATORY CARE SETTINGS
    • 13.3.1 THE RISING NEED TO CONTROL HEALTHCARE COSTS DRIVES THE DEMAND FOR CDSS IN AMBULATORY CARE SETTINGS
    • TABLE 33 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR AMBULATORY CARE SETTINGS, BY REGION, 2020-2027 (USD MILLION)

14 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION

  • 14.1 INTRODUCTION
    • FIGURE 26 NORTH AMERICA TO DOMINATE THE CDSS MARKET FROM 2022 TO 2027
    • TABLE 34 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 14.2 NORTH AMERICA
    • FIGURE 27 NORTH AMERICA: CDSS MARKET SNAPSHOT
    • TABLE 35 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 36 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 37 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020-2027 (USD MILLION)
    • TABLE 38 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 39 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 40 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020-2027 (USD MILLION)
    • TABLE 41 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 42 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 43 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020-2027 (USD MILLION)
    • 14.2.1 US
      • 14.2.1.1 The US is the largest market for CDSS solutions
    • TABLE 44 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 45 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020-2027 (USD MILLION)
    • TABLE 46 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 47 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 48 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020-2027 (USD MILLION)
    • TABLE 49 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 50 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 51 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020-2027 (USD MILLION)
    • 14.2.2 CANADA
      • 14.2.2.1 The rising requirement for cost containment drives the market growth in Canada
    • TABLE 52 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 53 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020-2027 (USD MILLION)
    • TABLE 54 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 55 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 56 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020-2027 (USD MILLION)
    • TABLE 57 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 58 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 59 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020-2027 (USD MILLION)
  • 14.3 EUROPE
    • TABLE 60 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 61 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 62 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020-2027 (USD MILLION)
    • TABLE 63 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 64 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 65 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020-2027 (USD MILLION)
    • TABLE 66 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 67 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 68 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020-2027 (USD MILLION)
    • 14.3.1 GERMANY
      • 14.3.1.1 Government initiatives to boost the adoption of EMRs drives the market growth in Germany
    • TABLE 69 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 70 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020-2027 (USD MILLION)
    • TABLE 71 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 72 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 73 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020-2027 (USD MILLION)
    • TABLE 74 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 75 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 76 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020-2027 (USD MILLION)
    • 14.3.2 UK
      • 14.3.2.1 Favorable government initiatives drive the demand for CDSS solutions in the UK
    • TABLE 77 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 78 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020-2027 (USD MILLION)
    • TABLE 79 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 80 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 81 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020-2027 (USD MILLION)
    • TABLE 82 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 83 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 84 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020-2027 (USD MILLION)
    • 14.3.3 FRANCE
      • 14.3.3.1 The rising focus on improving the healthcare system in France drives the market demand for CDSS
    • TABLE 85 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 86 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020-2027 (USD MILLION)
    • TABLE 87 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 88 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 89 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020-2027 (USD MILLION)
    • TABLE 90 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 91 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 92 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020-2027 (USD MILLION)
    • 14.3.4 ITALY
      • 14.3.4.1 The growing burden of chronic diseases drives the adoption of EHR solutions in Italy
    • TABLE 93 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 94 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020-2027 (USD MILLION)
    • TABLE 95 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 96 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 97 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020-2027 (USD MILLION)
    • TABLE 98 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 99 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 100 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020-2027 (USD MILLION)
    • 14.3.5 SPAIN
      • 14.3.5.1 Growing cases of COVID-19 have driven the demand for evidence-based solutions in Spain
    • TABLE 101 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 102 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020-2027 (USD MILLION)
    • TABLE 103 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 104 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 105 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020-2027 (USD MILLION)
    • TABLE 106 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 107 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 108 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020-2027 (USD MILLION)
    • 14.3.6 REST OF EUROPE
    • TABLE 109 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 110 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020-2027 (USD MILLION)
    • TABLE 111 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 112 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 113 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020-2027 (USD MILLION)
    • TABLE 114 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 115 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 116 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020-2027 (USD MILLION)
  • 14.4 ASIA PACIFIC
    • FIGURE 28 ASIA PACIFIC: CDSS MARKET SNAPSHOT
    • TABLE 117 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 118 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 119 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020-2027 (USD MILLION)
    • TABLE 120 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 121 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 122 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020-2027 (USD MILLION)
    • TABLE 123 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 124 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 125 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020-2027 (USD MILLION)
    • 14.4.1 JAPAN
      • 14.4.1.1 The rising geriatric population in Japan supports the adoption of evidence-based clinical decisions using CDSS
    • TABLE 126 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 127 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020-2027 (USD MILLION)
    • TABLE 128 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 129 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 130 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020-2027 (USD MILLION)
    • TABLE 131 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 132 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 133 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020-2027 (USD MILLION)
    • 14.4.2 CHINA
      • 14.4.2.1 China is a lucrative market for HCIT solutions due to strong government support for healthcare reforms
    • TABLE 134 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 135 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020-2027 (USD MILLION)
    • TABLE 136 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 137 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 138 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020-2027 (USD MILLION)
    • TABLE 139 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 140 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 141 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020-2027 (USD MILLION)
    • 14.4.3 INDIA
      • 14.4.3.1 The high burden of chronic diseases in India supports the market adoption of CDSS-based solutions
    • TABLE 142 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 143 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020-2027 (USD MILLION)
    • TABLE 144 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 145 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 146 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020-2027 (USD MILLION)
    • TABLE 147 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 148 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 149 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020-2027 (USD MILLION)
    • 14.4.4 REST OF ASIA PACIFIC (ROAPAC)
    • TABLE 150 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 151 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020-2027 (USD MILLION)
    • TABLE 152 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 153 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 154 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020-2027 (USD MILLION)
    • TABLE 155 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 156 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 157 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020-2027 (USD MILLION)
  • 14.5 REST OF THE WORLD
    • TABLE 158 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 159 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 160 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020-2027 (USD MILLION)
    • TABLE 161 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 162 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 163 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020-2027 (USD MILLION)
    • TABLE 164 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 165 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 166 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020-2027 (USD MILLION)
    • 14.5.1 LATIN AMERICA
      • 14.5.1.1 Developments in healthcare infrastructure support the market growth in Latin America
    • TABLE 167 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 168 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020-2027 (USD MILLION)
    • TABLE 169 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 170 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 171 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020-2027 (USD MILLION)
    • TABLE 172 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 173 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 174 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020-2027 (USD MILLION)
    • 14.5.2 MIDDLE EAST & AFRICA
      • 14.5.2.1 Growing medical tourism supports the market adoption of CDSS in the Middle East & Africa
    • TABLE 175 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020-2027 (USD MILLION)
    • TABLE 176 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020-2027 (USD MILLION)
    • TABLE 177 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 178 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 179 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020-2027 (USD MILLION)
    • TABLE 180 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020-2027 (USD MILLION)
    • TABLE 181 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 182 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020-2027 (USD MILLION)

15 COMPETITIVE LANDSCAPE

  • 15.1 OVERVIEW
  • 15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • TABLE 183 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE CLINICAL DECISION SUPPORT SYSTEMS MARKET
  • 15.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
    • FIGURE 29 REVENUE ANALYSIS OF KEY PLAYERS IN THE CLINICAL DECISION SUPPORT SYSTEMS MARKET
  • 15.4 MARKET RANKING OF PLAYERS, 2021
    • FIGURE 30 CLINICAL DECISION SUPPORT SYSTEMS MARKET RANKING, BY KEY PLAYER, 2021
  • 15.5 COMPETITIVE BENCHMARKING
    • TABLE 184 CLINICAL DECISION SUPPORT SYSTEMS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS
    • TABLE 185 CLINICAL DECISION SUPPORT SYSTEMS MARKET: APPLICATION & PRODUCT FOOTPRINT OF KEY PLAYERS
    • TABLE 186 CLINICAL DECISION SUPPORT SYSTEMS MARKET: REGIONAL FOOTPRINT OF KEY PLAYERS
  • 15.6 COMPETITIVE LEADERSHIP MAPPING
    • 15.6.1 STARS
    • 15.6.2 EMERGING LEADERS
    • 15.6.3 PERVASIVE PLAYERS
    • 15.6.4 PARTICIPANTS
    • FIGURE 31 CLINICAL DECISION SUPPORT SYSTEMS MARKET (GLOBAL) COMPANY EVALUATION MATRIX, 2021
  • 15.7 COMPETITIVE LEADERSHIP MAPPING - START-UPS/SMES
    • 15.7.1 PROGRESSIVE COMPANIES
    • 15.7.2 STARTING BLOCKS
    • 15.7.3 RESPONSIVE COMPANIES
    • 15.7.4 DYNAMIC COMPANIES
    • FIGURE 32 COMPETITIVE LEADERSHIP MAPPING, START-UP/SME MATRIX MARKET
  • 15.8 COMPETITIVE SITUATIONS AND TRENDS
    • TABLE 187 PRODUCT LAUNCHES/ENHANCEMENTS
    • 15.8.1 DEALS
    • TABLE 188 DEALS, JANUARY 2019-MAY 2022

16 COMPANY PROFILES

  • (Business overview, Products & services offered, Recent developments & MnM View)**
  • 16.1 KEY PLAYERS
    • 16.1.1 CERNER CORPORATION
    • TABLE 189 CERNER: BUSINESS OVERVIEW
    • FIGURE 33 CERNER CORPORATION: COMPANY SNAPSHOT (2019)
    • 16.1.2 IBM WATSON HEALTH
    • TABLE 190 IBM: BUSINESS OVERVIEW
    • FIGURE 34 IBM: COMPANY SNAPSHOT (2021)
    • 16.1.3 CHANGE HEALTHCARE
    • TABLE 191 CHANGE HEALTHCARE: BUSINESS OVERVIEW
    • FIGURE 35 CHANGE HEALTHCARE: COMPANY SNAPSHOT (2021)
    • 16.1.4 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
    • TABLE 192 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: BUSINESS OVERVIEW
    • FIGURE 36 ALLSCRIPTS HEALTHCARE, LLC: COMPANY SNAPSHOT (2021)
    • 16.1.5 ATHENAHEALTH
    • TABLE 193 ATHENAHEALTH: BUSINESS OVERVIEW
    • 16.1.6 EPIC SYSTEMS CORPORATION
    • TABLE 194 EPIC SYSTEMS CORPORATION: BUSINESS OVERVIEW
    • 16.1.7 ELSEVIER B.V. (A DIVISION OF RELX GROUP)
    • TABLE 195 ELSEVIER B.V.: BUSINESS OVERVIEW
    • 16.1.8 ZYNX HEALTH
    • TABLE 196 ZYNX HEALTH: BUSINESS OVERVIEW
    • 16.1.9 WOLTERS KLUWER N.V.
    • TABLE 197 WOLTERS KLUWER N.V.: BUSINESS OVERVIEW
    • FIGURE 37 WOLTERS KLUWER N.V.: COMPANY SNAPSHOT (2021)
    • 16.1.10 PHILIPS HEALTHCARE (A SUBSIDIARY OF ROYAL PHILIPS)
    • TABLE 198 PHILIPS HEALTHCARE: BUSINESS OVERVIEW
    • FIGURE 38 PHILIPS HEALTHCARE: COMPANY SNAPSHOT (2021)
    • 16.1.11 MEDITECH
    • TABLE 199 MEDITECH: BUSINESS OVERVIEW
  • *Details on Business overview, Products & services offered, Recent developments & MnM View might not be captured in case of unlisted companies.
  • 16.2 OTHER KEY PLAYERS
    • 16.2.1 NEXTGEN HEALTHCARE
    • 16.2.2 SIEMENS HEALTHINEERS
    • 16.2.3 EBSCO HEALTH (A DIVISION OF EBSCO INDUSTRIES, INC.)
    • 16.2.4 GE HEALTHCARE
    • 16.2.5 ECLINICALWORKS
    • 16.2.6 RAMPMEDICAL
    • 16.2.7 THE MEDICAL ALGORITHMS COMPANY
    • 16.2.8 HERA-MI
    • 16.2.9 CUREMD
    • 16.2.10 CARECLOUD
    • 16.2.11 VISUALDX
    • 16.2.12 STANSON HEALTH
    • 16.2.13 FIRST DATABANK
    • 16.2.14 STRATA DECISION TECHNOLOGY

17 APPENDIX

  • 17.1 DISCUSSION GUIDE
  • 17.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 17.3 AVAILABLE CUSTOMIZATIONS
  • 17.4 RELATED REPORTS
  • 17.5 AUTHOR DETAILS